ESC Premium Access

SYNTAX II trial: five year follow-up

Congress Presentation

About the speaker

Professor Adrian Paul Banning

John Radcliffe Hospital, Oxford (United Kingdom of Great Britain & Northern Ireland)
7 presentations
0 follower

2 more presentations in this session

Antiplatelet therapy in high bleeding risk patients with and without oral anticoagulant therapy after coronary stenting

Speaker: Doctor P. Smits (Rotterdam, NL)


TWILIGHT-HBR: Ticagrelor Monotherapy in High Bleeding Risk Patients

Speaker: Doctor D. Cao (Bergamo, IT)


Access the full session

Trial Updates in ACS & PCI

Speakers: Professor A. Banning, Doctor P. Smits, Doctor D. Cao

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Hot topics in atrial fibrillation.

5 April 2022

ESC Premium Access

Choosing wisely: ablation or medication for rhythm control in atrial fibrillation – discussion.

27 August 2021

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC 365 is supported by

logo Novo Nordisk